Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bonnie Ky"'
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 379-384 (2020)
JACC. CardioOncology
JACC. CardioOncology
Remarkable progress in cancer treatments has resulted in improved long-term survival. However, cardiovascular complications related to these therapies may result in treatment interruptions and worse oncologic and cardiovascular outcomes. Early diagno
Autor:
Bonnie Ky, Cristina Salvadori Bittar, Sheila Aparecida Coelho Siqueira, Ludhmila Abrahão Hajjar, Fernanda A. de S. Costa, Andre Abdo, Juliana Pereira, Vanderson Rocha, Stephanie Itala Rizk, Isabela Bispo Santos da Silva Costa
Publikováno v:
JACC: CardioOncology
JACC. CardioOncology, Vol 2, Iss 2, Pp 324-328 (2020)
JACC. CardioOncology, Vol 2, Iss 2, Pp 324-328 (2020)
Erdheim-Chester disease (ECD) is classified as an inflammatory myeloid neoplasia that has an unknown origin and low incidence (∼600 cases described in the literature) ([1][1],[2][2]). ECD is multisystemic, affecting the bones, skin, ocular tissue,
Autor:
Rebecca A. Hubbard, Hayley Knollman, Srinivas Denduluri, Kelly D. Getz, Vivek Narayan, Bonnie Ky, Amy S. Clark, Payal D. Shah, Joseph R. Carver, Richard Aplenc, Biniyam G. Demissei, Srinath Adusumalli
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 2, Pp 179-189 (2020)
JACC: CardioOncology
JACC: CardioOncology
Background: There is limited evidence regarding the impact of cardiology involvement in the care of cancer patients. Objectives: This study evaluated the impact of cardiology involvement on guideline-adherent cardiovascular monitoring and risk factor
Autor:
Eileen P. Dimond, Bonnie Ky, Myrtle Davis, Eric J. Chow, W. Gregory Hundley, Pamela S. Douglas, Richard Fagerstrom, Carol J. Fabian, Joseph M. Unger, Karen M. Mustian, Justin D. Floyd, Saro H. Armenian, Lori M. Minasian, Bishow B. Adhikari, Steven E. Lipshultz
Publikováno v:
JACC CardioOncol
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
JACC. CardioOncology, Vol 1, Iss 1, Pp 105-113 (2019)
Cardiovascular (CV) toxicity from cancer therapy is a significant and growing concern. Conventional oncology clinical trial designs focused solely on cancer treatment efficacy have not provided sufficient information on both CV risk factors and outco
Autor:
Bonnie Ky
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 532-534 (2020)
JACC: CardioOncology
JACC: CardioOncology
[Figure][1] One year ago, we launched the first issue of JACC: CardioOncology, wherein I outlined my vision for this journal: to become the essential resource for the field of cardio-oncology; to play a vital and transformative role in advancing the
Autor:
Bonnie Ky
Publikováno v:
JACC: CardioOncology
JACC. CardioOncology, Vol 2, Iss 1, Pp 146-148 (2020)
JACC. CardioOncology, Vol 2, Iss 1, Pp 146-148 (2020)
[Figure][1] “I am a survivor. Bring it on.”—From my patient, a survivor of 4 cancers, cardiac arrest, and heart failure in response to the question, “What first comes to mind when hearing cancer and heart disease?” The resiliency and streng
Autor:
Bonnie Ky
Publikováno v:
JACC: CardioOncology
JACC. CardioOncology, Vol 1, Iss 2, Pp 291-292 (2019)
JACC. CardioOncology, Vol 1, Iss 2, Pp 291-292 (2019)
[Figure][1] My breath in is gratitude, and my breath out is helping others.—Shared by Dr. Kalpana and Uday Patankar In my role as the Editor-in-Chief of JACC: CardioOncology, I am driven by the tremendous opportunity to inform and advance the field
Autor:
Bonnie Ky
Publikováno v:
JACC: CardioOncology
JACC. CardioOncology, Vol 1, Iss 1, Pp 131-132 (2019)
JACC. CardioOncology, Vol 1, Iss 1, Pp 131-132 (2019)
[Figure][1] I first became interested in the field of cardio-oncology as a young cardiology fellow. I was fascinated by mechanisms of cardiovascular disease. With the guidance of wonderful mentors, I was driven to understand further how perturbation